REGISTRATION STATEMENT

Company

CNS Pharmaceuticals, Inc.

Filed

December 8, 2023

Accession Number

0001683168-23-008734

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →